Conagra Brands, Inc. (CAG)

Regulus Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts that cover Regulus Therapeutics stock have a consensus rating of "Hold" and an average price target of $21.9, which forecasts a 17.17% increase in the stock price over the next year. The lowest target is $20 and the highest is $26.

Price Target: $21.90 (+17.17%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$20	$21.9	$21	$26
Change	+7.01%	+17.17%	+12.36%	+39.11%

Analyst Ratings

The average analyst rating for Regulus Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	9	9	9	8	7	7
Sell	0	0	0	1	1	1
Strong Sell	0	0	0	1	1	1
Total	10	10	10	11	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bryan Adams UBS	UBS	Hold Maintains $21 → $20	Hold	Maintains	$21 → $20	+7.01%	Jul 11, 2025
David Palmer Evercore ISI Group	Evercore ISI Group	Hold Maintains $26 → $24	Hold	Maintains	$26 → $24	+28.41%	Jul 11, 2025
Matthew Smith Stifel	Stifel	Hold Maintains $26 → $21	Hold	Maintains	$26 → $21	+12.36%	Jul 11, 2025
Chris Carey Wells Fargo	Wells Fargo	Hold Maintains $22 → $20	Hold	Maintains	$22 → $20	+7.01%	Jul 11, 2025
Nik Modi RBC Capital	RBC Capital	Hold Maintains $25 → $22	Hold	Maintains	$25 → $22	+17.71%	Jul 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

11.41B

Decreased by -1.78%

from 11.61B

Revenue Next Year

11.32B

Decreased by -0.73%

from 11.41B

EPS This Year

2.21

Decreased by -7.77%

from 2.40

EPS Next Year

2.33

Increased by 5.17%

from 2.21

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	May 30, 2021	May 29, 2022	May 28, 2023	May 26, 2024	May 25, 2025	May 25, 2026	May 25, 2027	May 25, 2028
Revenue	11.18B	11.54B	12.28B	12.05B	11.61B	11.41B	11.32B	11.51B
Revenue Growth	1.18%	3.14%	6.42%	-1.84%	-3.64%	-1.78%	-0.73%	1.68%
EPS	2.66	1.84	1.42	0.72	2.40	2.21	2.33	2.51
EPS Growth	54.65%	-30.83%	-22.83%	-49.30%	233.33%	-7.77%	5.17%	7.81%
Forward PE	-	-	-	-	-	8.44	8.03	7.45
No. Analysts	-	-	-	-	-	21	15	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029
High	12.3B	12.2B	12.4B
Avg	11.4B	11.3B	11.5B
Low	10.9B	10.7B	10.9B

Revenue Growth

Revenue Growth	2026	2027	2028	2029
High	6.0%	6.8%	9.3%
Avg	-1.8%	-0.7%	1.7%
Low	-6.6%	-6.6%	-4.1%

EPS Forecast

EPS	2026	2027	2028	2029
High	2.57	2.65	2.79
Avg	2.21	2.33	2.51
Low	1.87	2.13	2.27

EPS Growth

EPS Growth	2026	2027	2028	2029
High	7.2%	19.5%	20.0%
Avg	-7.8%	5.2%	7.8%
Low	-22.1%	-3.9%	-2.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.